Editorial: Gene therapy for hearing loss: from mechanism to clinic, volume II

Shengyu Zou; Qingyin Zheng; Yu Sun; Xiaolong Fu; Wenjie Zhou; Zuhong He

doi:10.3389/fnins.2024.1412981

Editorial: Gene therapy for hearing loss: from mechanism to clinic, volume II

Front Neurosci. 2024 May 14:18:1412981. doi: 10.3389/fnins.2024.1412981. eCollection 2024.

Authors

Shengyu Zou¹, Qingyin Zheng², Yu Sun³, Xiaolong Fu⁴, Wenjie Zhou⁵, Zuhong He^{1

6}

Affiliations

¹ Department of Otorhinolaryngology-Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.
² Department of Otolaryngology-Head and Neck Surgery, Case Western Reserve University, Cleveland, OH, United States.
³ Department of Otorhinolaryngology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
⁴ School of Life Sciences, Shandong Provincial ENT Hospital, Shandong University, Jinan, China.
⁵ Songjiang Research Institute and Songjiang Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
⁶ State Key Laboratory of Digital Medical Engineering, Department of Otolaryngology Head and Neck Surgery, Zhongda Hospital, School of Life Sciences and Technology, Advanced Institute for Life and Health, Jiangsu Province High-Tech Key Laboratory for Bio-Medical Research, Southeast University, Nanjing, China.

No abstract available

Keywords: biomaterials; gene therapy; hair cell; hearing loss; hearing regeneration; presbycusis.

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the grants from National Natural Science Foundation of China (grant nos. 82222017 and 82271183), funding from the Key Research and Development Program of Hubei Province (grant no. 2022BCA046), and funding from the Fundamental Research Funds for the Central Universities (grant no. 2042022kf0059).